Toshio Hirano
Toshio Hirano (平野 俊夫, Hirano Toshio, born April 17, 1947 in Osaka, Japan) is a Japanese immunologist and academic, best known for his discovery of interleukin-6.[1][2] Since August 2011, he has served as the 17th President of Osaka University.
Toshio Hirano | |
---|---|
Hirano in 2009 | |
Born | |
Nationality | Japan |
Alma mater | Osaka University |
Known for | Discovery of interleukin-6 and its application in treating diseases |
Awards | Crafoord Prize (2009) Japan Prize (2011) |
Scientific career | |
Fields | Bioscience and Medical Science |
Chronology
- 1972 - graduated from Graduate School of Medicine, Osaka University[2]
- 1980 - assistant professor in the School of Medicine, Kumamoto University[2]
- 1984 - assistant professor at Institute for Molecular and Cellular Biology, Osaka University[2]
- 1989 - professor at the same university[2]
- 2004 - Dean of Graduate School of Frontier Biosciences, Osaka University[2]
- 2008 - Dean of Graduate School of Medicine, Osaka University[2]
- August 2011 - the 17th president of Osaka University[3]
Honors and awards
- Erwin von Balz prize (Japan), 1986
- CIBA-GEIGY Rheumatism Prize (Japan), 1990
- Sandoz Prize for Immunology, 1992
- Osaka Science Prize (Japan), 1997
- Mochida Memorial Prize (Japan), 1998
- ISI Citation Laureate Award (Japan), 1981–98, 2000
- The Fujihara Award, 2004 The Fujiwara Foundation of Science
- Medical Award of The Japan Medical Association, 2005, The Japan Medical Association
- Medal of Honor with Purple Ribbon, April, 2006
- The Crafoord Prize in Polyarthritis 2009
- The Japan Prize for the discovery of interleukin-6, 2011
References
Wikimedia Commons has media related to Toshio Hirano. |
- "Curriculum Vitae". University of Osaka. Retrieved 2009-07-09.
- http://www.japanprize.jp/en/prize_prof_2011_hirano.html, the Japan Prize Foundation
- "Archived copy". Archived from the original on 2012-04-04. Retrieved 2011-11-25.CS1 maint: archived copy as title (link), Osaka University president profile
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.